1. Lack of myeloid differentiation primary response protein MyD88 L265P mutation in primary cutaneous marginal zone lymphoma. (11th October 2015) Authors: Brenner, I.; Roth, S.; Flossbach, L.; Wobser, M.; Rosenwald, A.; Geissinger, E. Journal: British journal of dermatology Issue: Volume 173:Number 6(2015:Dec.) Page Start: 1527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD68 expression is a discriminative feature of indolent cutaneous CD8‐positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8‐positive cutaneous lymphomas. (15th April 2015) Authors: Wobser, M.; Roth, S.; Reinartz, T.; Rosenwald, A.; Goebeler, M.; Geissinger, E. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Genetic alterations in CD30-positive lymphoproliferations. (2019) Authors: Maurus, K.; Roth, S.; Appenzeller, S.; Goebeler, M.; Rosenwald, A.; Geissinger, E.; Wobser, M. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Sequential comprehensive molecular work-up of treatment-resistant mycosis fungoides with systemic dissemination during a 4-year period. (2019) Authors: Wobser, M.; Roth, S.; Olk, J.; Kneitz, H.; Goebeler, M.; Rosenwald, A.; Geissinger, E.; Maurus, K. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Low-dose gemcitabine therapy in CTCL: 'real-life" data of the German Cutaneous Lymphoma Network. (2019) Authors: Blazejak, C.; Stranzenbach, R.; Gambichler, T.; Stendel, S.; Wehkamp, U.; Klemke, C.-D.; Wobser, M.; Olk, J.; Nicolay, J.; Stadler, R.; Assaf, C. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study. (2019) Authors: Molloy, K.; Jonak, C.; Sherida, F.J.; Woei-A-Ji, H.; Guenova, E.; Busschots, A.M.; Bervoets, A.; Hauben, E.; Knobler, R.; Porkert, S.; Fassnacht, C.; Cowan, R.; Papadavid, E.; Beylot-Barry, M.; Berti, E.; Alberti Violetti, S.; Estrach, T.; Matin, R.; Akilov, O.; Vakeva, L. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A study of quality of life in people with mycosis fungoides and Sézary syndrome. (28th February 2020) Authors: Molloy, K.; Jonak, C.; Sherida, F.J.; Woei‐A‐Ji, H.; Guenova, E.; Busschots, A.M.; Bervoets, A.; Hauben, E.; Knobler, R.; Porkert, S.; Fassnacht, C.; Cowan, R.; Papadavid, E.; Beylot‐Barry, M.; Berti, E.; Alberti Violetti, S.; Estrach, T.; Matin, R.; Akilov, O.; Vakeva, L. Journal: British journal of dermatology Issue: Volume 182:Number 3(2020) Page Start: e96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 样肉芽肿和 Sézary 综合征患者生活质量研究. (28th February 2020) Authors: Molloy, K.; Jonak, C.; Sherida, F.J.; Woei‐A‐Ji, H.; Guenova, E.; Busschots, A.M.; Bervoets, A.; Hauben, E.; Knobler, R.; Porkert, S.; Fassnacht, C.; Cowan, R.; Papadavid, E.; Beylot‐Barry, M.; Berti, E.; Alberti Violetti, S.; Estrach, T.; Matin, R.; Akilov, O.; Vakeva, L. Journal: British journal of dermatology Issue: Volume 182:Number 3(2020) Page Start: e109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. (28th July 2019) Authors: Molloy, K.; Jonak, C.; Woei‐A‐Jin, F.J.S.H.; Guenova, E.; Busschots, A.M.; Bervoets, A.; Hauben, E.; Knobler, R.; Porkert, S.; Fassnacht, C.; Cowan, R.; Papadavid, E.; Beylot‐Barry, M.; Berti, E.; Alberti Violetti, S.; Estrach, T.; Matin, R.; Akilov, O.; Vakeva, L.; Prince, M. Journal: British journal of dermatology Issue: Volume 182:Number 3(2020) Page Start: 770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Most rare subtypes of cutaneous lymphoma display variable CD30 expression: analysis of the German Cutaneous Lymphoma Network. (7th May 2021) Authors: Wehkamp, U.; Mitteldorf, C.; Stendel, S.; Stranzenbach, R.; Nicolay, J.P.; Wobser, M.; Weichenthal, M.; Schneiderbauer, R.; Klemke, C.‐D.; Hillen, U.; Kempf, W.; Assaf, C. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗